Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Alliance Foundation Trials, LLC.
Adicet Therapeutics
Dana-Farber Cancer Institute
City of Hope Medical Center
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
AbbVie
Memorial Sloan Kettering Cancer Center
Hackensack Meridian Health
Ohio State University Comprehensive Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Cellectar Biosciences, Inc.
Galapagos NV
Merck Sharp & Dohme LLC
University of Washington
The Lymphoma Academic Research Organisation
Eli Lilly and Company
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Acerta Pharma BV
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Acerta Pharma BV
AstraZeneca
City of Hope Medical Center
University of Michigan Rogel Cancer Center
Acerta Pharma BV
Guangzhou Lupeng Pharmaceutical Company LTD.
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fondazione Italiana Linfomi - ETS
M.D. Anderson Cancer Center
Gilead Sciences
Sana Biotechnology
City of Hope Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
University of Washington
AstraZeneca
Regeneron Pharmaceuticals
City of Hope Medical Center
City of Hope Medical Center
Sana Biotechnology